349.2 𩺠åèç
349.2.1 é«é »èé»
349.2.1.2 DU vs GU
- DU: pain relieved by food; weight gain; rarely malignant
- GU: pain worsened by food; weight loss; biopsy mandatory
349.2.1.3 Complications
- Bleeding (most common)
- Perforation
- Penetration
- Gastric outlet obstruction
- Malignancy (GU)
349.2.1.4 H. pylori Testing
- Urea breath test (preferred non-invasive)
- Stool antigen
- Biopsy + CLO test
- Histology
- Serology (less specific)
349.2.1.5 H. pylori Treatment (Updated 2024)
Quadruple Therapy (preferred): - Bismuth + PPI + tetracycline + metronidazole à 14 d
Triple Therapy (clarithromycin): - PPI + clarithromycin + amoxicillin à 14 d - Only if clarithromycin resistance < 15%
Vonoprazan-Based (FDA 2022): - Vonoprazan + amoxicillin (dual) or + clarithromycin (triple) - 14 d - Higher eradication
Verification: UBT or stool antigen 4+ weeks after, off PPI 2 weeks
349.2.2 ææ··æ·æ¯èŒ
| Feature | DU | GU |
|---|---|---|
| Pain timing | 2-3 hr after meal; relieved | Worsened with food |
| Risk of malignancy | Rare | All need biopsy |
| H. pylori | 70-95% | 60-80% |
| Sleep | Night pain (2-3 AM) | Less |